Yu-Ih Hou – Mayor, New Taipei City, Taiwan
Yu-Ih Hou, mayor of New Taipei City, introduces the city and highlights its key competitive advantages and strategic direction of growth as Taiwan’s top economic and cultural destination. Over…
Address: 7th floor, No. 69, Lane 77, Xing-Ai Road, Neihu, Taipei,Taiwan
Tel: +886 2 2790 0799
Web: http://www.chifupharma.com/
Chi-Fu Trading Co., Ltd. provides turnkey solutions to manufacturers worldwide who are interested in entering the Taiwanese and Asian markets. Chi-Fu carefully researchs the markets, and communicates with customers. Chi-Fu also evaluates potential products for our clients in the Asian markets. With the combined efforts of manufacturers and our marketing staff, Chi-Fu improves the health of the citizens and enhances its suppliers’ market portfolios.
Chi-Fu Trading Co., Ltd. Will transform from its existing stage into “Chi-Fu Multinational Enterprise” to better reflect our market representations as well as our diverse product lines.
We stride to become a leader in distributing highly sophisticated medical equipment, devices, pharmaceuticals, consumables and bio technology related products.
We will hold leadership positions in all of our product and service areas and become the leader in all of the markets that we are present.
Chi-Fu will engage and become a leader in the health promotion service and hospital management consultation, working toward improving the health care of mankind.
Yu-Ih Hou, mayor of New Taipei City, introduces the city and highlights its key competitive advantages and strategic direction of growth as Taiwan’s top economic and cultural destination. Over…
Wei-Hong Tseng, founder and chairman of PharmaCore Biotech, introduces the specialized CDMO and its unique capacities to produce high value-added products. As a leading service provider in Taiwan, Tseng goes…
Carol Cheng, chief operating officer of the Taiwan Research-based Biopharmaceutical Manufacturers Association (TRPMA), gives an update on the current condition of Taiwan’s biopharma environment and speaks about the country’s innovative…
Bach Chen, CEO of Maisense, highlights the innovative new solutions that the company has created in cardiovascular preventative medicine. Their advanced technology, Freescan, is providing an advanced solution to prevent…
Alan Tsai, general manager, and Carson Chen, chief technology officer of iXensor introduce the startup as an innovative player in the point-of-care diagnostics and digital health space. They jointly discuss…
Dr Jan-Mou Lee, founder of FullHope Biomedical, shares his story of how he came to establish his company after a realization about the loss of impact that occurs when critical…
Arthur Kadurin, CEO of Insilico Medicine Taiwan, tells us how artificial intelligence can change drug discovery process using the innovative generative adversarial networks (GANs) approach. AI is the future…
Ed Deng, co-founder and CEO of Health2Sync, a digital health startup specialized in diabetes management, shares how the application is revolutionizing the ability of patients to take control of the…
Tsung-Tsong Wu, minister without portfolio, offers insights into the current state of Taiwan’s biomedical landscape three years after the administration’s Biomedical Industry Innovation Program was put into place to bolster…
Dr Tse Wen Chang, founder of Immunwork, gives an update on the preclinical development process of the company’s revolutionary T-E pharmaceutical products and goes on to give his expert insights…
Dr James Chih-Hsin Yang, director of National Taiwan University Hospital’s department of oncology, speaks about oncology in Taiwan and the role that the NTU network plays in the island’s oncology…
Rongjin Lin, chairman of Center Ventures and Center Laboratories shares his story of how he revived Center Laboratories from the brink of bankruptcy and repositioned the pharmaceutical company to become…
See our Cookie Privacy Policy Here
